Phase II HDM-SPIRE Safety and Efficacy Study
Public ClinicalTrials.gov record NCT02150343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the treatment effect of three treatment regimens of HDM-SPIRE vs placebo and to evaluates the treatment effect of HDM-SPIRE on symptoms, rescue medication usage, Quality of Life and Sleep Quality
Study identification
- NCT ID
- NCT02150343
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 715 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2014 (Type not available)
- Primary completion
- Apr 13, 2017 (Actual)
- Completion
- Apr 13, 2017 (Actual)
- Last update posted
- Jun 15, 2018
2014 – 2017
United States locations
- U.S. sites
- 56
- U.S. states
- 28
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntington Beach | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Mission Viejo | California | — | — |
| Not listed | Napa | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Redwood City | California | — | — |
| Not listed | Rolling Hills Estates | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Stockbridge | Georgia | — | — |
| Not listed | Normal | Illinois | — | — |
| Not listed | Shiloh | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Gaithersburg | Maryland | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Plymouth | Minnesota | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Bellevue | Nebraska | — | — |
| Not listed | Ocean City | New Jersey | — | — |
| Not listed | Teaneck | New Jersey | — | — |
| Not listed | Verona | New Jersey | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Rockville Centre | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Blue Bell | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Providence | Rhode Island | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Kerrville | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | South Burlington | Vermont | — | — |
| Not listed | Henrico | Virginia | — | — |
| Not listed | Bellingham | Washington | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Vancouver | Washington | — | — |
| Not listed | Greenfield | Wisconsin | — | — |
| Not listed | Madison | Wisconsin | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02150343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02150343 live on ClinicalTrials.gov.